V. Werth

838 total citations
18 papers, 105 citations indexed

About

V. Werth is a scholar working on Rheumatology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, V. Werth has authored 18 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 8 papers in Pathology and Forensic Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in V. Werth's work include Systemic Lupus Erythematosus Research (11 papers), Autoimmune Bullous Skin Diseases (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). V. Werth is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Autoimmune Bullous Skin Diseases (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). V. Werth collaborates with scholars based in United States, Switzerland and Sweden. V. Werth's co-authors include David Fiorentino, Michael Krathen, Jennifer S. Albrecht, Russell P. Hall, Donna A. Culton, Richard S. Blumberg, Ruofei Feng, Josef Symon S. Concha, Dania Rabah and Ada Azaryan and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Investigative Dermatology and Lupus.

In The Last Decade

V. Werth

16 papers receiving 103 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Werth United States 6 57 37 36 30 17 18 105
Ching-Tsai Lin Taiwan 7 98 1.7× 23 0.6× 22 0.6× 14 0.5× 9 0.5× 15 154
Hélène Bacquet-Deschryver France 3 87 1.5× 17 0.5× 44 1.2× 9 0.3× 7 0.4× 4 123
Ulrich Drott Germany 5 38 0.7× 25 0.7× 20 0.6× 10 0.3× 7 0.4× 6 96
Xavier Cubiró Spain 9 33 0.6× 29 0.8× 30 0.8× 32 1.1× 66 3.9× 20 147
Kiyohiro Tsutsui Japan 5 33 0.6× 17 0.5× 9 0.3× 24 0.8× 23 1.4× 9 89
Ryochi Yoshida Japan 7 48 0.8× 19 0.5× 37 1.0× 16 0.5× 4 0.2× 11 99
Albert Gil‐Vila Spain 7 55 1.0× 98 2.6× 17 0.5× 26 0.9× 22 1.3× 16 129
César Graf Argentina 5 93 1.6× 19 0.5× 23 0.6× 25 0.8× 3 0.2× 7 140
Jennifer Kwan‐Morley United States 3 63 1.1× 9 0.2× 63 1.8× 27 0.9× 7 0.4× 3 103
Mariko Ogawa‐Momohara Japan 7 50 0.9× 82 2.2× 31 0.9× 16 0.5× 19 1.1× 19 107

Countries citing papers authored by V. Werth

Since Specialization
Citations

This map shows the geographic impact of V. Werth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Werth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Werth more than expected).

Fields of papers citing papers by V. Werth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Werth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Werth. The network helps show where V. Werth may publish in the future.

Co-authorship network of co-authors of V. Werth

This figure shows the co-authorship network connecting the top 25 collaborators of V. Werth. A scholar is included among the top collaborators of V. Werth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Werth. V. Werth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Afarideh, Mohsen, et al.. (2022). 223 Evaluation of nailfold capillaries in dermatomyositis using a dermatoscope. Journal of Investigative Dermatology. 142(8). S38–S38.
4.
5.
Werth, V., et al.. (2022). OP0162 EFFICACY AND SAFETY OF LENABASUM IN THE PHASE 3 DETERMINE TRIAL IN DERMATOMYOSITIS. Annals of the Rheumatic Diseases. 81. 106–107. 10 indexed citations
6.
Werth, V., et al.. (2022). POS0367 IMPROVEMENT OF INDIVIDUAL MUCOCUTANEOUS MANIFESTATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH ANIFROLUMAB. Annals of the Rheumatic Diseases. 81. 436–437. 2 indexed citations
7.
Vollenhoven, Ronald van, Richard Furie, Kenneth Kalunian, et al.. (2021). POS0698 BIIB059 DEMONSTRATED A CONSISTENT THERAPEUTIC EFFECT ON SRI-4 RESPONSE ACROSS SUBGROUPS OF PARTICIPANTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN THE LILAC PHASE 2 STUDY. Annals of the Rheumatic Diseases. 80. 597–598. 1 indexed citations
8.
Maddukuri, Spandana, Jay Patel, Christina E. Bax, Maria Wysocka, & V. Werth. (2020). 885 Major producers of IFNg and CB2 receptor distribution in dermatomyositis. Journal of Investigative Dermatology. 140(7). S116–S116. 1 indexed citations
9.
Werth, V., S.M. Peña, Ruofei Feng, et al.. (2018). 605 Study of safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis. Journal of Investigative Dermatology. 138(5). S103–S103. 5 indexed citations
10.
Werth, V., et al.. (2018). 538 FcRn blockade with SYNT001 for the treatment of pemphigus. Journal of Investigative Dermatology. 138(5). S92–S92. 11 indexed citations
11.
12.
13.
14.
Werth, V., et al.. (2017). SAT0255 A randomized, placebo-controlled, double-blind, ascending-dose, safety study of CC-220 in subjects with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 76. 870–871. 5 indexed citations
15.
Furie, Richard, V. Werth, Joseph F. Merola, et al.. (2017). SAT0222 BIIB059, a monoclonal antibody targeting BDCA2, shows evidence of biological activity and early clinical proof of concept in subjects with active cutaneous le. Annals of the Rheumatic Diseases. 76. 857–857. 6 indexed citations
16.
Bisconte, Angelina, et al.. (2016). A new treatment for autoimmune blistering diseases- the efficacy of Bruton's tyrosinase kinase inhibitor PRN473 in canine pemphigus foliaceus. 2 indexed citations
17.
Albrecht, Jennifer S. & V. Werth. (2010). Clinical outcome measures for cutaneous lupus erythematosus. Lupus. 19(9). 1137–1143. 17 indexed citations
18.
Krathen, Michael, David Fiorentino, & V. Werth. (2008). Dermatomyositis. PubMed. 10. 313–332. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ching-Tsai Lin Breakdown of academic impact, for papers by Hélène Bacquet-Deschryver Breakdown of academic impact, for papers by Ulrich Drott Breakdown of academic impact, for papers by Xavier Cubiró Breakdown of academic impact, for papers by Kiyohiro Tsutsui Breakdown of academic impact, for papers by Ryochi Yoshida Breakdown of academic impact, for papers by Albert Gil‐Vila Breakdown of academic impact, for papers by César Graf Breakdown of academic impact, for papers by Jennifer Kwan‐Morley Breakdown of academic impact, for papers by Mariko Ogawa‐Momohara
Rankless by CCL
2026